Article Versions Notes

Bülbül EF, Robaa D, Sun P, Mahmoudi F, Melesina J, Zessin M, Schutkowski M, Sippl W. Application of Ligand- and Structure-Based Prediction Models for the Design of Alkylhydrazide-Based HDAC3 Inhibitors as Novel Anti-Cancer Compounds. Pharmaceuticals. 2023; 16(7):968. https://doi.org/10.3390/ph16070968

Bülbül, Emre F., Dina Robaa, Ping Sun, Fereshteh Mahmoudi, Jelena Melesina, Matthes Zessin, Mike Schutkowski, and Wolfgang Sippl. 2023. "Application of Ligand- and Structure-Based Prediction Models for the Design of Alkylhydrazide-Based HDAC3 Inhibitors as Novel Anti-Cancer Compounds" Pharmaceuticals 16, no. 7: 968. https://doi.org/10.3390/ph16070968

Bülbül, E. F., Robaa, D., Sun, P., Mahmoudi, F., Melesina, J., Zessin, M., Schutkowski, M., & Sippl, W. (2023). Application of Ligand- and Structure-Based Prediction Models for the Design of Alkylhydrazide-Based HDAC3 Inhibitors as Novel Anti-Cancer Compounds. Pharmaceuticals, 16(7), 968. https://doi.org/10.3390/ph16070968